Skip to main content

DNA Editing as a Therapeutic Modality for Rett Syndrome

February 16, 2021
cure_360_webinar_youtube_thumbnail_-_dna_editing_1500_x_700_px

In this episode of the ongoing webinar series hosted by Rett Syndrome Research Trust, we are joined by Jonathan Watts, PhD, and Kevin Luk and Karthik Ponnienselvan, members of the Scot Wolfe Lab, to discuss how DNA editing is a promising therapeutic modality for Rett Syndrome.

Recording

More Resources

Our Plan for a Cure: DNA Editing

$40M